23/S/25/SU/DG/A/AM32 Non-exclusive medications for human use type I - Included in therapeutic group D, G and H. Lote 17. Atosiban 6,75 Mg/0,9 Ml Vial Parenteral
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
23/S/25/SU/DG/A/AM32 Non-exclusive medications for human use type I - Included in therapeutic group D, G and H. Lote 17. Atosiban 6,75 Mg/0,9 Ml Vial Parenteral
Lote 17. Atosiban 6,75 Mg/0,9 Ml Vial Parenteral
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals